Advancing Safe Medications for Moms and Babies Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Advancing Safe Medications for Moms and Babies Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Education.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HB165CF9D97CF421E8DCE8A362404848E: 1. Short title This Act may be cited as the Advancing Safe Medications for Moms and Babies Act of 2026.
- Section H72DF3F1C150A4A41891ED60B847AD85E: 2. Updating FDA regulations to include pregnant women in clinical trials The purposes of this section are— to facilitate compliance with applicable Federal...
- Section H879E7654177249DF8DB85584F14F3AEF: 3. Raising awareness of research that includes pregnant and lactating women The Secretary of Health and Human Services (referred to in this section as the...
- Section H7E67DFFE9E1A4641862F4742EDCADBC6: 4. Research prioritization process for pregnant and lactating women at the Eunice Kennedy Shriver National Institute of Child Health and Human Development The...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Advancing Safe Medications for Moms and Babies Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Education
Primary Purpose
This bill, Advancing Safe Medications for Moms and Babies Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the House Committee on Energy and Commerce.
Introduced in House
Ms. Castor of Florida (for herself, Mr. Fitzpatrick, and Ms. …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology